Symposium on Alzheimer's Disease in the Middle East

中东阿尔茨海默病研讨会

• 批准号: 6998344
• 负责人: ROBERT PAUL FRIEDLAND
• 金额: $ 3万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2006-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6998344
• 关键词: Alzheimer' s disease; Middle East; dementia; meeting /conference /symposium; neural degeneration; travel

DESCRIPTION (provided by applicant): Alzheimer's disease is a major health problem and the leading cause of dementia in the Americas and Europe. Although there has been little work done on dementia in the Middle East, there is evidence-from our studies in Arabs residing in Israel-that Alzheimer's disease has a high prevalence in Arabs (20% over 60, 60% over 85 years of age). This high prevalence is over three times higher than in other populations, even after correcting for the effects of age, gender and education. This is an important issue because of the progressive aging of the population of the Middle East as we enter the 21st century. Public awareness of dementia in the Middle East is low, and in many cases does not receive medical attention. The goals of this Symposium are to focus attention on neurodegenerative disorders of the aged in the Middle East, to raise scientific, medical and social awareness of these disorders, and to enhance communication between Arab and Jewish medical and scientific personnel. It is anticipated that the meeting will lead to other studies in Middle East populations, an area with unique features valuable for research, including a high rate of consanguinity, high fat diet, and smoking. A target audience of clinicians, scientists, nurses, social workers, government representatives and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in Istanbul, Turkey, October 1-2, 2005. The meeting will be a satellite to the 21st International Conference of Alzheimer's Disease International. Attendees will be from Egypt, Saudi Arabia, Jordan, Qatar, Bahrain, and other Arab states, as well as from Israel, Europe, and North America. Topics to be covered include dementia, basic science, diagnoses, history, management and treatment, and ethics, with consideration of the unique cultural traditions of Arab and Jewish populations.

描述（由申请人提供）：阿尔茨海默病是一个主要的健康问题，是美洲和欧洲痴呆症的主要原因。虽然在中东地区对痴呆症的研究很少，但我们对居住在以色列的阿拉伯人的研究表明，阿尔茨海默病在阿拉伯人中的患病率很高（60岁以上20%，85岁以上60%）。即使在对年龄、性别和教育的影响进行校正之后，这种高流行率也比其他人群高出三倍以上。这是一个重要的问题，因为在我们进入21世纪时，中东人口逐渐老龄化。中东地区的公众对痴呆症的认识很低，在许多情况下没有得到医疗照顾。这次专题讨论会的目标是集中注意中东老年人的神经退行性疾病，提高科学、医学和社会对这些疾病的认识，并加强阿拉伯和犹太医学和科学人员之间的交流。预计这次会议将导致对中东人口的其他研究，这一地区具有独特的研究价值，包括高血缘率，高脂肪饮食和吸烟。临床医生、科学家、护士、社会工作者、政府代表和其他机构、制药公司和其他生物技术公司的目标受众将出席2005年10月1日至2日在土耳其伊斯坦布尔举行的会议。这次会议将是第21届阿尔茨海默病国际会议的卫星会议。与会者将来自埃及、沙特阿拉伯、约旦、卡塔尔、巴林和其他阿拉伯国家，以及以色列、欧洲和北美。将涵盖的主题包括痴呆症、基础科学、诊断、历史、管理和治疗以及伦理，同时考虑到阿拉伯和犹太人口的独特文化传统。